Paris, France

Mélanie Albert

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Institut Pasteur. Active years: 2021-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mélanie Albert. Retrieved from https://idiyas.com/inventor/mélanie-albert

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Inventor Mélanie Albert

Introduction

Mélanie Albert is a prominent inventor based in Paris, France. He has made significant contributions to the field of biotechnology, particularly in the detection of viral pathogens. With a total of 2 patents, his work has garnered attention for its relevance in public health.

Latest Patents

Mélanie Albert's latest patents focus on methods and reagents for the specific and sensitive detection of SARS-CoV-2. These patents include methods, primers, sets of primers, probes, compositions, and kits designed to detect the presence or absence of SARS-CoV-2 in a sample. His innovative approaches are crucial in the ongoing efforts to manage and control the COVID-19 pandemic.

Career Highlights

Mélanie Albert is affiliated with the Institut Pasteur, a renowned research institution known for its contributions to the study of infectious diseases. His work at this prestigious institute has allowed him to collaborate with leading scientists and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Flora Donati and Sylvie Behillil. Their collaborative efforts have further advanced the research and development of effective detection methods for viral infections.

Conclusion

Mélanie Albert's contributions to the field of biotechnology, particularly in the detection of SARS-CoV-2, highlight his innovative spirit and dedication to public health. His work continues to play a vital role in the fight against infectious diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…